Minerva Neurosciences (NERV) Misses Q3 EPS by 3c

November 3, 2016 8:42 AM EDT
Get Alerts NERV Hot Sheet
Trade NERV Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21).

Cash, cash equivalents and marketable securities as of September 30, 2016 were approximately $91.9 million, compared to $32.2 million as of December 31, 2015. As previously stated, Minerva expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operations into 2018.

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment